In short. The melasma that heat makes worse, the skin states that postpone both routes, and the situations where a peel is the safer of the two options.
Key points
- A superficial chemical peel produces a more predictable and more superficial injury than an energy-based treatment, because its depth is governed by the agent and the contact time rather than by how much heat the skin absorbs.
- For surface pigment on skin that has reacted badly to light, a superficial peel is therefore sometimes the safer of the two routes.
- It is not gentle by default, and the irritation it creates still has to be controlled with spacing and aftercare.
Melasma is provoked by inflammation, and heat is one of the ways skin becomes inflamed. That makes heat-based treatment a particular concern in this condition, and it makes some cases of melasma unsuitable for it.
The cases that should avoid heat
Melasma that is currently active is the clearest example. When the pigment is deepening, spreading or changing week to week, the skin is already in a reactive state, and adding an energy-based treatment on top of that is adding to a fire rather than settling it. The usual advice is to wait, protect the skin and treat topically until the activity settles.
Melasma that has already darkened after previous treatment is the second. If a laser or a peel has made the area worse before, the skin has demonstrated how it responds to that kind of injury, and repeating it is unlikely to produce a different result. Pigment that sits deep is the third: the energy required to reach it is greater, and so is the heat deposited in the skin above it.
Where a peel is the more cautious of the two
A superficial chemical peel produces a more predictable and more superficial injury than an energy-based treatment, because its depth is governed by the agent and the contact time rather than by how much heat the skin absorbs. For surface pigment on skin that has reacted badly to light, a superficial peel is therefore sometimes the safer of the two routes. It is not gentle by default, and the irritation it creates still has to be controlled with spacing and aftercare.
The states that postpone both
Some skin states are reasons to defer treatment rather than to choose between the two routes. Skin that is inflamed, infected, sunburnt or recently treated carries more risk from either. Pregnancy and breastfeeding usually defer treatment, because hormonal change is driving the pigment and the response to treatment is less predictable. Some medicines make the skin photosensitive, which changes how it responds to light. And recent sun exposure or a tan means the skin is already responding to ultraviolet, so the additional irritation is poorly tolerated and the risk of a pigmentary change is higher.
Reasons to defer rather than choose
- Melasma that is currently deepening or spreading, rather than stable.
- Skin that is inflamed, sunburnt, infected, or has been treated recently.
- Pregnancy, breastfeeding, or a medicine that makes the skin photosensitive.
The question to ask is not which of the two suits your melasma but whether your skin is in a state to be treated at all. If it is not, the correct answer is that neither route should be started now, and that is a plan rather than a refusal.
Frequently asked questions
Why does heat matter more than light in melasma?
Because the pigment cells in melasma-prone skin respond to inflammation, and heat is one of the ways skin becomes inflamed. Energy delivered as heat adds to the inflammatory load the skin has to settle, and in skin that is already reactive that can tip the balance towards more pigment rather than less. It is why melasma settings are kept low rather than set to what the device could deliver.
When is a peel the safer of the two routes?
When the pigment sits superficially, when the skin has reacted badly to light-based treatment before, or when the area involved is small and the depth is within a superficial peel's reach. In those situations a peel produces a more predictable and more superficial injury. It is not risk-free, and the irritation it creates still has to be controlled.
Are there skin states where neither should be used?
Yes. Skin that is currently inflamed, infected, sunburnt or recently treated is not treated with either. Pregnancy and breastfeeding usually defer treatment, and so do some medicines that make the skin photosensitive. Recent sun exposure or a tan is a reason to wait, because the skin is already responding to ultraviolet and the additional irritation is poorly tolerated.
Risks & Limitations
- Rebound darkening. Melasma-prone skin produces more pigment in response to inflammation, and both a laser and a peel create inflammation deliberately.
- Blistering, crusting or a burn if the settings or the contact time do not match the skin, with a small risk of scarring.
- Post-inflammatory pigment change in either direction, darker in most cases and lighter in some.
- Infection in skin that has been broken, and uneven peeling after a chemical agent.
- An allergic reaction to the peeling agent, which is a reason a test spot comes first.
- Increased sun sensitivity after either route, while the skin is settling and afterwards.
- Melasma is a tendency, not a lesion. Neither route removes it, both are followed by maintenance, and the pigment usually returns.
- No outcome is guaranteed, and individual response varies with the depth of the pigment, the skin type and how consistently the skin is protected.
When to Seek Care
- Blistering, crusting or a burn in the treated area — contact the treating team the same day.
- The treated area becoming darker rather than lighter after a session has settled.
- Spreading redness, swelling, pain or discharge, or a fever.
- Skin that stays red, stings or feels reactive between sessions rather than returning to normal.
- A dark patch that is new, changing in size, shape or colour, bleeding or failing to heal — seek assessment rather than treatment.
- Difficulty breathing, or swelling of the lips, tongue or throat after a chemical peel — seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology Association (AAD) — patient information on melasma and pigmentary disorders
- British Association of Dermatologists (BAD) — guidance on laser and light therapy and on chemical peels
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance on skin lesions and referral
- Cochrane Library — systematic reviews in the treatment of melasma
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.